Latest news
RevMed, BeOne make clinical trial, Asia deal; MoonLake reports Phase 3 win - Endpoints NewsEndpoints News · Mon, 10 Aug 2026 15:33:00 GMTAvere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001 - PR NewswirePR Newswire · Mon, 10 Aug 2026 11:00:00 GMTIPO News - US IPO Weekly Recap: August kicks off with flurry of biotech IPOs - renaissancecapital.comrenaissancecapital.com · Fri, 07 Aug 2026 22:26:43 GMTNextCure (NXTC) details two-step Avere merger plan and upcoming Form S-4 - Stock TitanStock Titan · Tue, 04 Aug 2026 11:35:04 GMTThe week in pharma: action, reaction and insight – week to July 31, 2026 - thepharmaletter.comthepharmaletter.com · Sun, 02 Aug 2026 12:50:13 GMT